Suppr超能文献

长期疗效及重复关节内注射肉毒杆菌毒素对全关节置换术后疼痛患者的疗效:一项回顾性研究

Efficacy of Long-term Effect and Repeat Intraarticular Botulinum toxin in Patients with Painful Total Joint Arthroplasty: A Retrospective Study.

作者信息

Singh Jasvinder A

机构信息

Medicine Service and Center for Surgical Medical Acute Care Research and Transitions (C-SMART), Birmingham VA Medical Center, Birmingham, AL; USA ; Department of Medicine, University of Alabama, and Division of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL; USA. ; Department of Orthopedic Surgery, Mayo Clinic School of Medicine, Rochester, MN, USA.

出版信息

Br J Med Med Res. 2014 Jan;4(1):139-48. doi: 10.9734/BJMMR/2014/4897.

Abstract

OBJECTIVE

Based on recent success of intra-articular (IA) Botulinum neurotoxin type A (BoNT/A; OnabotulinumtoxinA) in patients with osteoarthritis, we examined if repeat IA-BoNT/A is an effective antinociceptive in patients with refractory arthroplasty pain.

METHODS

11 patients with refractory chronic arthroplasty joint pain without any evidence of infection or prosthesis loosening were referred by orthopedic surgeons. After discussion of off-label use, each patient underwent IA injection of BoNT/A, repeated based on return of pain on numeric rating scale (NRS) and functional limitation on composite validated scales, Western Ontario McMaster Osteoarthritis index (WOMAC) or Shoulder Pain and Disability (SPADI).

RESULTS

11 patients (10 men, 1 woman) with 14 painful arthroplasty joints (3 bilateral; 12 knee and 2 shoulder) underwent ≥1 IA-BoNT/A injections (8 joints injected once, one joint injected twice only, five joints injected thrice) with doses ranging 100-300 units. Mean age was 68 years (standard deviation, 12) and follow-up ranged 1-28 months. Clinically meaningful reduction of 2-units in pain severity and really meaningful reduction in pain severity (50% reduction) were reported by 6/11 patients (6/13 joints) and 3/11 patients (3/13 joints), respectively, 1 month after the first IA-BoNT/A (100-units each). Significant improvements were noted in composite functional scales (WOMAC/SPADI). Pain relief was sustained at 3-4 month follow-up and was reproducible in those who received repeat injections. No significant adverse events were seen in any patients.

CONCLUSIONS

A single intra-articular injection of BoNT/A improved pain and function in patients with chronic, refractory painful knee or shoulder arthroplasty, which sustained with repeat injections. Patients who were refractory to the first injection, did not respond to subsequent injections of higher dose of IA-BoNT/A.

摘要

目的

基于关节内注射A型肉毒杆菌神经毒素(BoNT/A;奥曲肽)治疗骨关节炎患者近期取得的成功,我们研究了重复关节内注射BoNT/A对难治性关节置换术后疼痛患者是否具有有效的镇痛作用。

方法

11例难治性慢性关节置换术后关节疼痛且无任何感染或假体松动迹象的患者由骨科医生转诊而来。在讨论了药物的非标签使用后,每位患者接受关节内注射BoNT/A,根据数字评分量表(NRS)上疼痛的复发情况以及综合验证量表(西安大略和麦克马斯特大学骨关节炎指数(WOMAC)或肩痛与功能障碍指数(SPADI))上的功能受限情况重复注射。

结果

11例患者(10例男性,1例女性),共14个疼痛的关节置换关节(3例双侧;12例膝关节和2例肩关节)接受了≥1次关节内注射BoNT/A(8个关节注射1次,1个关节仅注射2次,5个关节注射3次),剂量范围为100 - 300单位。平均年龄为68岁(标准差12),随访时间为1 - 28个月。首次关节内注射BoNT/A(每次100单位)1个月后,分别有6/11例患者(6/13个关节)报告疼痛严重程度临床上有意义地降低2个单位,3/11例患者(3/13个关节)报告疼痛严重程度有真正有意义的降低(降低50%)。综合功能量表(WOMAC/SPADI)有显著改善。在3 - 4个月的随访中疼痛缓解持续存在且在接受重复注射的患者中可再现。所有患者均未出现明显不良事件。

结论

单次关节内注射BoNT/A可改善慢性难治性膝关节或肩关节置换术后患者的疼痛和功能,重复注射可持续这种效果。对首次注射无效的患者,后续注射更高剂量的关节内BoNT/A也无反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a9/3850174/f3c3a6d626db/nihms530558f1a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验